)
Edge6 Feb 2026
SharkNinja: Viral by Design
How SharkNinja built a repeatable growth engine, turning overlooked appliance categories into global brands through consumer insight and iteration.
Navamedic
Navamedic (NAVA) investor relations material
Navamedic Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Feb, 2026
Executive summary
Q4 2025 revenue reached a record NOK 157.1 million, up 19.8% year-over-year, driven by the acquisition of DNE Pharma assets and strong growth in Antibiotics.
Full-year 2025 revenue was NOK 565.4 million, a 6.4% increase from 2024, with growth primarily from Antibiotics and the new Addiction portfolio.
Adjusted EBITDA for Q4 was NOK 13.4 million (8.5% margin), and for the full year NOK 47.6 million (8.4% margin), both excluding transaction costs.
Key milestones included the acquisition of DNE Pharma assets, launch of Flexilev in OraFID, and new distribution agreements.
Integration of the Addiction portfolio and expansion into the German market supported business growth.
Financial highlights
Q4 gross margin improved to 40.3% from 33.7% in Q4 2024; full-year gross margin was 39.0%.
Q4 adjusted EBITDA increased to NOK 13.4 million from a loss of NOK 3.2 million in Q4 2024.
Net profit for Q4 was a loss of NOK 11.1 million, and for the full year a loss of NOK 23.5 million, impacted by higher amortization and financial expenses.
Cash at year-end was NOK 74.2 million, up from NOK 37.3 million at the end of 2024.
Pro forma revenue for 2025, including full-year DNE effect, would be approximately NOK 600 million, a 12.9% increase over 2024.
Outlook and guidance
Modest revenue growth expected in 2026, with full-year contribution from the Addiction portfolio and Flexilev in OraFID, offset by phase-out of selected brands.
Improved gross margins and reduced operating expenses anticipated to positively impact EBITDA.
Additional growth initiatives, including market expansion for Flexilev, Ventizolve, Absolut Torr, and further in-licensing, out-licensing, and M&A, are being actively pursued.
Flexelev US market entry strategy
Majzimba vs GLP-1s: How to maintain share?
Drivers for 2026 EBITDA improvement
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Navamedic earnings date
Q1 202623 Apr, 2026
Navamedic
Next Navamedic earnings date
Q1 202623 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Navamedic ASA is a Norwegian pharmaceutical company focused on developing, producing, marketing, and distributing a range of healthcare products. Its portfolio includes both prescription and non-prescription pharmaceuticals, medical nutrition products, medical devices, and consumer health items such as food supplements and cosmetics. The company primarily serves hospitals, pharmacies, and patients across the Nordic countries, Benelux, and the Baltics, with additional presence in the UK and other European markets. The company is headquartered in Oslo, Norway, and its shares are listed on the Oslo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage